Back to Agenda
Topic 2 Session 5: Expedited Reporting Requirements in the Post-authorisation Phase and Case Studies
Speaker(s)
Expedited Reporting Requirements in the Post-authorisation Phase and Case Studies
Gaby L. Danan, MD, PhD
GLD, France
Pharmacovigilance Expert
Have an account?